Skip to main content
. 2014 Jul;6(7):958–964. doi: 10.3978/j.issn.2072-1439.2014.07.18

Table 2. Objective responses (n=38).

Pemetrexed n (%) Icotinib n (%)
CR 0 (0) 0 (0)
PR 8 (21.1) 16 (42.2)
SD 13 (34.2) 11 (28.9)
PD 17 (44.7) 11 (28.9)
ORR (CR + PR) 8 (21.1) 16 (42.2)
DCR (CR + PR + SD) 21 (55.3) 27 (71.1)

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, overall response rate; DCR, disease control rate.